AstraZeneca's Major China Investment and NYSE Listing to Drive Pharma Innovation
Pharma heavyweight AstraZeneca recently announced its decision to invest a staggering $15 billion in China, a move aligned with its strategic partnership with a Chinese biotech firm focused on developing.....
Subscribe for Full Access!
Gain valuable sourcing and trade intelligence from our database of millions of data points spanning 20+ years!
